Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

NCT05636852 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision

Conditions

Parkinson Disease
Movement Disorders

Interventions

DRUG: Altropane (123I) Injection

Sponsor

GE Healthcare

Collaborators

[object Object]